Progyny Inc (PGNY) - Total Liabilities
Based on the latest financial reports, Progyny Inc (PGNY) has total liabilities worth $226.39 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PGNY cash generation efficiency to assess how effectively this company generates cash.
Progyny Inc - Total Liabilities Trend (2017–2025)
This chart illustrates how Progyny Inc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Progyny Inc to evaluate the company's liquid asset resilience ratio.
Progyny Inc Competitors by Total Liabilities
The table below lists competitors of Progyny Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Concentrix Corporation
NASDAQ:CNXC
|
USA | $7.89 Billion |
|
Tessenderlo
BR:TESB
|
Belgium | €1.03 Billion |
|
Faes Farma SA
MC:FAE
|
Spain | €594.19 Million |
|
Fair Oaks Income Limited
LSE:FAIR
|
UK | $270.92K |
|
Shenzhen Yanmade Technology Inc
SHG:688312
|
China | CN¥327.04 Million |
|
Huabao Flavours & Fragrances Co Ltd Class A
SHE:300741
|
China | CN¥491.05 Million |
|
Jiangsu Sanfangxiang Industry Co Ltd
SHG:600370
|
China | CN¥14.28 Billion |
|
Global Blue Group Holding Ltd
NYSE:GB
|
USA | $1.03 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Progyny Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Progyny Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Progyny Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Progyny Inc (2017–2025)
The table below shows the annual total liabilities of Progyny Inc from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $226.39 Million | +22.35% |
| 2024-12-31 | $185.04 Million | -8.93% |
| 2023-12-31 | $203.19 Million | +22.39% |
| 2022-12-31 | $166.02 Million | +56.26% |
| 2021-12-31 | $106.24 Million | +22.15% |
| 2020-12-31 | $86.98 Million | +140.52% |
| 2019-12-31 | $36.16 Million | +19.74% |
| 2018-12-31 | $30.20 Million | +24.44% |
| 2017-12-31 | $24.27 Million | -- |
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers … Read more